Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry

American Heart Journal

Volumn 159, Issue 4, 2010, Pages

  Duvernoy, Claire S ^a   Smith, Dean E ^a   Manohar, Prerana ^b   Schaefer, Ann ^b   Kline Rogers, Eva ^a   Share, David ^a   McNamara, Richard ^b   Gurm, Hitinder S ^a   Moscucci, Mauro ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Meijer Heart Center

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD TRANSFUSION; BODY SURFACE; CLINICAL ASSESSMENT; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DEATH; DEMOGRAPHY; EMERGENCY SURGERY; FEMALE; HEART INFARCTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SEX DIFFERENCE; STROKE;

EID: 77950128171     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.040     Document Type: Article

References (19)

1. American Heart Association. Statistical fact sheet-populations:women and cardiovascular diseases-statistics (2004), American Heart Association
2. Mehilli J., Kastrati A., Dirschinger J., et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 284 (2000) 1799-1805
3. Peterson E.D., Lansky A.J., Kramer J., et al. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 88 (2001) 359-364
4. Malenka D.J., Wennberg D.E., Quinton H.A., et al. Northern New England Cardiovascular Disease Study Group: gender-related changes in the practice and outcomes of percutaneous coronary interventions in northern New England from 1994 to 1999. J Am Coll Cardiol 40 (2002) 2092-2101
5. QuickFacts USCBSaC: population, 2007 estimate.
6. Moscucci M., Share D., Kline-Rogers E., et al. The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J Interv Cardiol 15 (2002) 381-386
7. Moscucci M., Share D., Smith D., et al. Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database. J Am Coll Cardiol 46 (2005) 625-632
8. Moscucci M., Rogers E.K., Montoye C., et al. Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions. Circulation 113 (2006) 814-822
9. Malenka D.J., O'Connor G.T., Quinton H., et al. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group. Circulation 94 (1996) II99-II104
10. Ashby DT, Mehran R, Aymong EA, et al., Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries. Am J Cardiol 91:979-981, A974, A977, 2003.
11. Iakovou I., Dangas G., Mehran R., et al. Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors. Am J Cardiol 89 (2002) 976-979
12. Lansky A.J., Pietras C., Costa R.A., et al. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 111 (2005) 1611-1618
13. Lansky A.J., Hochman J.S., Ward P.A., et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 111 (2005) 940-953
14. Grossman P.M., Gurm H.S., McNamara R., et al. Percutaneous coronary intervention complications and guide catheter size: bigger is not better. JACC Cardiovasc Interv 2 (2009) 636-644
15. Latif F., Kleiman N.S., Cohen D.J., et al., on behalf of the EVENT Investigators. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) Registry. J Am Coll Cardiol Intv 2 (2009) 37-45
16. Rubenstein M.H., Harrell L.C., Sheynberg B.V., et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?. Circulation 102 (2000) 2966-2972
17. Best P.J., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
18. Kahn J.K., Rutherford B.D., McConahay D.R., et al. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 119 (1990) 484-489
19. Alexander K.P., Chen A.Y., Newby L.K., et al., for the CRUSADE Investigators. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative. Circulation 114 (2006) 1380-1387